High resolution mass spectrometry‐based methodologies for identification of Etravirine bioactivation to reactive metabolites: In vitro and in vivo approaches

[1]  M. Prudêncio,et al.  Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds , 2017, Front. Cell. Infect. Microbiol..

[2]  C. Jacob,et al.  Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study , 2016, Archives of Toxicology.

[3]  G. Rutherford,et al.  Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals , 2016, The Cochrane database of systematic reviews.

[4]  A. Njunda,et al.  The prevalence of malaria in people living with HIV in Yaounde, Cameroon , 2016, BMC Public Health.

[5]  M. Suiko,et al.  Sulfation of benzyl alcohol by the human cytosolic sulfotransferases (SULTs): a systematic analysis , 2016, Journal of applied toxicology : JAT.

[6]  A. Kulkarni,et al.  Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability , 2016, Drug metabolism letters.

[7]  B. Godman,et al.  A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications , 2016, Expert review of anti-infective therapy.

[8]  Tsuneo Hashizume,et al.  The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment. , 2016, Mutagenesis.

[9]  M. Grillo.  Detecting reactive drug metabolites for reducing the potential for drug toxicity , 2015, Expert opinion on drug metabolism & toxicology.

[10]  N. Tretyakova,et al.  DNA-Protein Cross-Links: Formation, Structural Identities, and Biological Outcomes. , 2015, Accounts of chemical research.

[11]  C. Falany,et al.  Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis. , 2015, Drug metabolism and pharmacokinetics.

[12]  M. Darnell,et al.  Metabolism of xenobiotic carboxylic acids: focus on coenzyme A conjugation, reactivity, and interference with lipid metabolism. , 2013, Chemical research in toxicology.

[13]  J. Uetrecht,et al.  12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash. , 2013, Chemical research in toxicology.

[14]  N. Tretyakova,et al.  1,2,3,4-Diepoxybutane-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells. , 2013, Journal of proteome research.

[15]  B. K. Park,et al.  Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients. , 2013, Chemical research in toxicology.

[16]  N. Grilo,et al.  Evidence for nevirapine bioactivation in man: searching for the first step in the mechanism of nevirapine toxicity. , 2012, Toxicology.

[17]  U. Argikar.  Unusual Glucuronides , 2012, Drug Metabolism and Disposition.

[18]  J. Croxtall,et al.  Etravirine , 2012, Drugs.

[19]  Namandjé N. Bumpus,et al.  Biotransformation of the Antiretroviral Drug Etravirine: Metabolite Identification, Reaction Phenotyping, and Characterization of Autoinduction of Cytochrome P450-Dependent Metabolism , 2012, Drug Metabolism and Disposition.

[20]  L. Le Marchand,et al.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. , 2011, Chemical research in toxicology.

[21]  H. Laverty,et al.  Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. , 2011, Chemico-biological interactions.

[22]  C. Reust.  Common adverse effects of antiretroviral therapy for HIV disease. , 2011, American family physician.

[23]  F. Beland,et al.  Protein adducts as prospective biomarkers of nevirapine toxicity. , 2010, Chemical research in toxicology.

[24]  G. Rutherford,et al.  Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. , 2010, The Cochrane database of systematic reviews.

[25]  L. Peterson,et al.  Identification of furan metabolites derived from cysteine-cis-2-butene-1,4-dial-lysine cross-links. , 2010, Chemical research in toxicology.

[26]  M. Schöller-Gyüre,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Etravirine , 2009, Clinical pharmacokinetics.

[27]  J. Uetrecht,et al.  Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash. , 2008, Chemical research in toxicology.

[28]  E. Seminari,et al.  Etravirine for the treatment of HIV infection , 2008, Expert review of anti-infective therapy.

[29]  D. Tan,et al.  Intermolecular protein cross-linking during acrolein toxicity: efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells. , 2007, Chemical research in toxicology.

[30]  K. Knights,et al.  Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acids , 2007, Expert opinion on drug metabolism & toxicology.

[31]  Shufeng Zhou,et al.  Bioactivation and hepatotoxicity of nitroaromatic drugs. , 2006, Current drug metabolism.

[32]  H. Desaire,et al.  Identification of sulfation sites of metabolites and prediction of the compounds’ biological effects , 2006, Analytical and bioanalytical chemistry.

[33]  A. Kalgutkar,et al.  On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. , 2002, Current drug metabolism.

[34]  J. Uetrecht,et al.  N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS , 2002, Drug metabolism reviews.

[35]  R. Pollard,et al.  Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. , 1998, Clinical therapeutics.

[36]  T. Rustan,et al.  Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. , 1993, Cancer research.

[37]  S. Tannenbaum,et al.  Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. , 1987, Cancer research.